{
  "list": [
    {
      "id": "chads2-score-for-atrial-fibrillation",
      "title": "CHADS2 Score for Atrial Fibrillation"
    },
    {
      "id": "curb-65-pneumonia-severity-score",
      "title": "CURB-65 Pneumonia Severity Score"
    },
    {
      "id": "ransons-criteria-for-pancreatitis-mortality",
      "title": "Ranson's Criteria for Pancreatitis Mortality"
    }
  ],
  "calculators": [
    {
      "id": "chads2-score-for-atrial-fibrillation",
      "title": "CHADS2 Score for Atrial Fibrillation",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Congestive Heart Failure History",
          "data": {
            "type": "radio",
            "options": "No/Yes",
            "points": "0/1"
          }
        },
        {
          "group": "Hypertension history",
          "data": {
            "type": "radio",
            "options": "No/Yes",
            "points": "0/1"
          }
        },
        {
          "group": "Age â‰¥ 75 years",
          "data": {
            "type": "radio",
            "options": "No/Yes",
            "points": "0/1"
          }
        },
        {
          "group": "Diabetes melitus history",
          "data": {
            "type": "radio",
            "options": "No/Yes",
            "points": "0/1"
          }
        },
        {
          "group": "Stroke or TIA symptoms previously",
          "data": {
            "type": "radio",
            "options": "No/Yes",
            "points": "0/2"
          }
        }
      ],
      "results": {
        "0": [
          "Low risk of thromboembolic event. 1.9% risk of event per year if no coumadin.",
          "The adjusted stroke rate was the expected stroke rate per 100 person-years derived from the multivariable model assuming that aspirin was not taken."
        ],
        "1": [
          "Intermediate risk of thromboembolic event. 2.8% risk of event per year if no coumadin.",
          "The adjusted stroke rate was the expected stroke rate per 100 person-years derived from the multivariable model assuming that aspirin was not taken."
        ],
        "2": [
          "Intermediate risk of thromboembolic event. 4.0% risk of event per year if no coumadin.",
          "The adjusted stroke rate was the expected stroke rate per 100 person-years derived from the multivariable model assuming that aspirin was not taken."
        ],
        "3": [
          "High risk of thromboembolic event. 5.9% risk of event per year if no coumadin.",
          "The adjusted stroke rate was the expected stroke rate per 100 person-years derived from the multivariable model assuming that aspirin was not taken."
        ],
        "4": [
          "High risk of thromboembolic event. 8.5% risk of event per year if no coumadin.",
          "The adjusted stroke rate was the expected stroke rate per 100 person-years derived from the multivariable model assuming that aspirin was not taken."
        ],
        "5": [
          "Note: While history of stroke provides 2 points, most physicians would move these patients directly to the high risk group (>8.5% risk of event per year if no coumadin.)",
          "By points directly: High risk of thromboembolic event. 12.5% risk of event per year if no coumadin.",
          "The adjusted stroke rate was the expected stroke rate per 100 person-years derived from the multivariable model assuming that aspirin was not taken."
        ],
        "6": [
          "Note: While history of stroke provides 2 points, most physicians would move these patients directly to the high risk group (>8.5% risk of event per year if no coumadin.)",
          "By points directly: High risk of thromboembolic event. 18.2% risk of event per year if no coumadin.",
          "The adjusted stroke rate was the expected stroke rate per 100 person-years derived from the multivariable model assuming that aspirin was not taken."
        ]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "Estimates stroke risk in patients with atrial fibrillation",
          "The CHADS2 score is one of several risk stratification schemes that can help determine the 1 year risk of an ischemic stroke in a non-anticoagulated patient with non-valvular atrial fibrillation and determine which antithrombotic therapy is most appropriate",
          "The CHA2-DS2-VASC score may be a better tool to assess stroke risk in patients with atrial fibrillation.  It risk stratifies these patients better than the CHADS2 score"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Gage BF, Waterman AD, Shannon W, et. al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001 Jun 13;285(22):2864-70.",
          "Go AS, Hylek EM, Chang Y, et. al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?. JAMA. 2003 Nov 26;290(20):2685-92."
        ]
      }
    },
    {
      "id": "curb-65-pneumonia-severity-score",
      "title": "CURB-65 Pneumonia Severity Score",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Confusion (abbreviated Mental Test Score <=8)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Urea (BUN > 19 mg/dL or 7 mmol/L)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Respiratory Rate > 30 per minute",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Blood Pressure: diastolic < 60 or systeolic < 90 mmHg",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Age >= 65 years",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0": [
          "Low risk group: 0.6% 30-day mortality.",
          "Consider outpatient treatment."
        ],
        "1": [
          "Low risk group: 2.7% 30-day mortality.",
          "Consider outpatient treatment."
        ],
        "2": [
          "Moderate risk group: 6.8% 30-day mortality.",
          "Consider inpatient treatment or outpatient with close followup."
        ],
        "3": [
          "Severe risk group: 14.0% 30-day mortality.",
          "Consider inpatient treatment with possible intensive care admission."
        ],
        "4": [
          "Highest risk group: 27.8% 30-day mortality.",
          "Consider inpatient treatment with possible intensive care admission."
        ],
        "5": [
          "Highest risk group: 27.8% 30-day mortality.",
          "Consider inpatient treatment with possible intensive care admission."
        ]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "CURB-65 estimates the mortality of community-acquired pneumonia to help determine inpatient vs outpatient treatment",
          "Compared to the Pneumonia Severity Index (PSI), CURB-65 offers equal sensitivity of mortality prediction due to community-acquired pneumonia.  In fact, CURB-65 has a higher specificity than PSI"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Lim WS, van der Eerden MM, Laing R, et. al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 May;58(5):377-82.",
          "Lim WS, Macfarlane JT, Boswell TC, et. al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001 Apr;56(4):296-301."
        ]
      }
    },
    {
      "id": "ransons-criteria-for-pancreatitis-mortality",
      "title": "Ranson's Criteria for Pancreatitis Mortality",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria at time of patient admission to hospital",
          "data": [
            {
              "type": "checkbox",
              "label": "Age > 55",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Glucose >200 mg/dL (>10 mmol/L)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "WBC > 16,000",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "AST > 250",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "LDH > 350",
              "points": "1"
            }
          ]
        },
        {
          "group": "Criteria that may develop over the first 2 hospital days",
          "data": [
            {
              "type": "checkbox",
              "label": "Hct drop >10% from admission",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "BUN increase >5 mg/dL (>1.79 mmol/L) from admission",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Ca <8 mg/dL (<2 mmol/L) within 48 hours",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Arterial pO2 <60 mmHg within 48 hours",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Base deficit (24 - HCO3) >4 mg/dL within 48 hours",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Fluid needs > 6L within 48 hours",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "group": "Criteria at time of patient admission to hospital",
          "data": {
            "0": [
              "Ransonâ€™s Criteria (On Admission)",
              "Severe pancreatitis unlikely."
            ],
            "1": [
              "Ransonâ€™s Criteria (On Admission)",
              "Severe pancreatitis unlikely."
            ],
            "2": [
              "Ransonâ€™s Criteria (On Admission)",
              "Severe pancreatitis unlikely."
            ],
            "3": [
              "Ransonâ€™s Criteria (On Admission)",
              "Severe pancreatitis likely. Consider ICU admission."
            ],
            "4": [
              "Ransonâ€™s Criteria (On Admission)",
              "Severe pancreatitis likely. Consider ICU admission."
            ],
            "5": [
              "Ransonâ€™s Criteria (On Admission)",
              "Severe pancreatitis likely. Consider ICU admission."
            ]
          }
        },
        {
          "group": "Cumulative",
          "data": {
            "0": [
              "Ransonâ€™s Criteria (Cumulative)",
              "1% predicted mortality."
            ],
            "1": [
              "Ransonâ€™s Criteria (Cumulative)",
              "1% predicted mortality."
            ],
            "2": [
              "Ransonâ€™s Criteria (Cumulative)",
              "1% predicted mortality."
            ],
            "3": [
              "Ransonâ€™s Criteria (Cumulative)",
              "15% predicted mortality."
            ],
            "4": [
              "Ransonâ€™s Criteria (Cumulative)",
              "15% predicted mortality."
            ],
            "5": [
              "Ransonâ€™s Criteria (Cumulative)",
              "50% predicted mortality."
            ],
            "6": [
              "Ransonâ€™s Criteria (Cumulative)",
              "40% predicted mortality."
            ],
            "7": [
              "Ransonâ€™s Criteria (Cumulative)",
              "100% predicted mortality."
            ],
            "8": [
              "Ransonâ€™s Criteria (Cumulative)",
              "100% predicted mortality."
            ],
            "9": [
              "Ransonâ€™s Criteria (Cumulative)",
              "100% predicted mortality."
            ],
            "10": [
              "Ransonâ€™s Criteria (Cumulative)",
              "100% predicted mortality."
            ],
            "11": [
              "Ransonâ€™s Criteria (Cumulative)",
              "100% predicted mortality."
            ]
          }
        }
      ],
      "notes": {
        "type": "unordered-list",
        "content": [
          "Estimates mortality of patients with pancreatitis based on initial and 48 hour lab values",
          "The BISAP score is another alternative to estimate pancreatitis mortality with fewer variables that is as accurate"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Ranson JH, Rifkind KM, Turner JW. Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gyne Ob. 143:209, 1976."
        ]
      }
    }
  ]
}
